Weires M, Bermejo JL, Sundquist J, Hemminki K. Clustering of concordant and discordant cancer types in Swedish couples is rare. Eur J Cancer. 2011;47:98–106.

Article  PubMed  Google Scholar 

Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database. Int J Cancer. 2002;99:260–6.

Article  CAS  PubMed  Google Scholar 

Lichtenstein P, Holm N, Verkasalo P, Illiado A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer. N Engl J Med. 2000;343:78–85.

Article  CAS  PubMed  Google Scholar 

Hemminki K, Sundquist K, Sundquist J, Försti A, Hemminki A, Li X. Familial risks and proportions describing population landscape of familial cancer. Cancers. 2021;13(17):4385.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hemminki K, Li X, Försti A, Eng C. Are population level familial risks and germline genetics meeting each other? Hered Cancer Clin Pract. 2023;21(1):3.

Article  PubMed  PubMed Central  Google Scholar 

Chubb D, Broderick P, Frampton M, Kinnersley B, Sherborne A, Penegar S, et al. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. J Clin Oncol. 2015;33(5):426–32.

Article  CAS  PubMed  Google Scholar 

Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2020;22(1):15–25.

Article  CAS  PubMed  Google Scholar 

Møller P, Seppälä TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, et al. Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut. 2018;67(7):1306–16.

Article  PubMed  Google Scholar 

Thomas M, Su YR, Rosenthal EA, Sakoda LC, Schmit SL, Timofeeva MN, et al. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations. Nat Commun. 2023;14(1):6147.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vietri MT, D’Elia G, Caliendo G, Casamassimi A, Federico A, Passariello L, et al. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer. Med Oncol. 2021;38(2):13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dörk T, Hillemanns P, Tempfer C, Breu J, Fleisch MC. Genetic susceptibility to endometrial cancer: risk factors and clinical management. Cancers. 2020;12(9):2407.

Article  PubMed  PubMed Central  Google Scholar 

Kral J, Jelinkova S, Zemankova P, Vocka M, Borecka M, Cerna L, et al. Germline multigene panel testing of patients with endometrial cancer. Oncol Lett. 2023;25(6):216.

Article  PubMed  PubMed Central  Google Scholar 

Cummings S, Alfonso A, Hughes E, Kucera M, Mabey B, Singh N, et al. Cancer risk associated with PTEN pathogenic variants identified using multigene hereditary cancer panel testing. JCO Precis Oncol. 2023;7:e2200415.

Article  PubMed  PubMed Central  Google Scholar 

Tzortzatos G, Aravidis C, Lindblom A, Mints M, Tham E. Screening for germline phosphatase and tensin homolog-mutations in suspected Cowden syndrome and Cowden syndrome-like families among uterine cancer patients. Oncol Lett. 2015;9(4):1782–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chung JH, Dewal N, Sokol E, Mathew P, Whitehead R, Millis SZ, et al. Prospective comprehensive genomic profiling of primary and metastatic prostate tumors. JCO Precis Oncol. 2019;3:PO.18.00283.

PubMed  PubMed Central  Google Scholar 

Pritzlaff M, Tian Y, Reineke P, Stuenkel AJ, Allen K, Gutierrez S, et al. Diagnosing hereditary cancer predisposition in men with prostate cancer. Genet Med. 2020;22(9):1517–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paulo P, Cardoso M, Brandão A, Pinto P, Falconi A, Pinheiro M, et al. Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients. Genes Chromosomes Cancer. 2023;62(12):710–20.

Article  CAS  PubMed  Google Scholar 

Liu H, Sundquist J, Hemminki K. Familial renal cell carcinoma from the Swedish family-cancer database. Eur Urol. 2011;60:987–93.

Article  PubMed  Google Scholar 

Yngvadottir B, Andreou A, Bassaganyas L, Larionov A, Cornish AJ, Chubb D, et al. Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases. Hum Mol Genet. 2022;31(17):3001–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hemminki K, Jiang Y, Ma X, Yang K, Egevad L, Lindblad P. Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors. Carcinogenesis. 2002;23(5):809–15.

Article  CAS  PubMed  Google Scholar 

Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, et al. Breast cancer risk genes - association analysis in more than 113,000 women. N Engl J Med. 2021;384(5):428–39.

Article  CAS  PubMed  Google Scholar 

Mavaddat N, Dorling L, Carvalho S, Allen J, González-Neira A, Keeman R, et al. Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes. JAMA Oncol. 2022;8(3):e216744.

Article  PubMed  PubMed Central  Google Scholar 

Xiao Q, Mao X, Ploner A, Grassmann F, Rodriguez J, Eriksson M, et al. Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer. J Natl Cancer Inst. 2024;116:911–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gronwald J, Cybulski C, Piesiak W, Suchy J, Huzarski T, Byrski T, et al. Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband. Br J Cancer. 2009;100(9):1508–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moslemi M, Vafaei M, Khani P, Soheili M, Nedaeinia R, Manian M, et al. The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a systematic review and meta-analysis. Cancer Cell Int. 2021;21(1):474.

Article  PubMed  PubMed Central  Google Scholar 

IARC. Personal habits and indoor combustions, vol. 100E. Lyon: International Agency for Research on Cancer; 2012. p. 575.

Tindle HA, Stevenson Duncan M, Greevy RA, Vasan RS, Kundu S, Massion PP, et al. Lifetime smoking history and risk of lung cancer: results from the Framingham heart study. J Natl Cancer Inst. 2018;110(11):1201–7.

PubMed  PubMed Central  Google Scholar 

Tichanek F, Försti A, Hemminki O, Hemminki A, Hemminki K. Survival in lung cancer in the Nordic countries through a half century. Clin Epidemiol. 2023;15:503–10.

Article  PubMed  PubMed Central  Google Scholar 

Patja K, Hakala SM, Boström G, Nordgren P, Haglund M. Trends of tobacco use in Sweden and Finland: do differences in tobacco policy relate to tobacco use? Scand J Public Health. 2009;37(2):153–60.

Article  PubMed  Google Scholar 

Hemminki K, Försti A, Hemminki A, Ljungberg B, Hemminki O. Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic. Eur J Cancer Prev. 2022;31(3):228–34.

Article  CAS  PubMed  Google Scholar 

Benusiglio PR, Fallet V, Sanchis-Borja M, Coulet F, Cadranel J. Lung cancer is also a hereditary disease. Eur Respir Rev. 2021;30(162):210045.